Kolchinsky Peter 4
4 · Dicerna Pharmaceuticals Inc · Filed Nov 26, 2019
Insider Transaction Report
Form 4
Kolchinsky Peter
Director10% Owner
Transactions
- Sale
Common Stock
2019-11-25$24.06/sh−361,200$8,689,677→ 883,576 total(indirect: See Note) - Sale
Common Stock
2019-11-22$22.52/sh−197,700$4,451,492→ 1,244,776 total(indirect: See Note) - Sale
Common Stock
2019-11-26$23.59/sh−239,700$5,653,444→ 643,876 total(indirect: See Note)
Footnotes (8)
- [F1]The securities sold include (a) 177,709 shares of Common Stock by RA Capital Healthcare Fund, L.P. (the "Fund") and (b) 19,991 shares of Common Stock by a separately managed account (the "Account").
- [F2]This transaction was executed in multiple trades at prices ranging from $22.16 to $22.82; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F3]RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Account. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP") of which Dr. Peter Kolchinsky is a managing member. Dr. Kolchinsky disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a)(2) under the Exchange Act except to the extent of his pecuniary interest therein.
- [F4]The securities sold include (a) 324,677 shares of Common Stock by the Fund and (b) 36,523 shares of Common Stock by the Account.
- [F5]This transaction was executed in multiple trades at prices ranging from $23.55 to $24.70; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F6]The securities sold include (a) 215,462 shares of Common Stock by the Fund and (b) 24,238 shares of Common Stock by the Account.
- [F7]This transaction was executed in multiple trades at prices ranging from $23.055 to $23.95; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F8]Following the reported transactions, the Fund held 578,769 shares and the Account held 65,107 shares.